Leonberger Polyneuropathy 2
LPN2 is a non-painful neurodegenerative condition leading to gradual muscle atrophy. LPN2 has been compared to the human condition Charcot-Marie-Tooth Disease.
-
Signs and symptoms
This can cause signs of weakness, laryngeal paralysis, and difficulty breathing. Dogs affected as young adults will often have more severe signs.
Development of signs is widely variable, from several months to 11 years of age. -
Diagnosis
Unless a genetic basis is suspected due to the age, breed, or history of the dog, diagnostics must be performed to rule out infectious, inflammatory, or neoplastic causes.
-
Treatment
There is no treatment for this disorder. Certain medications may be prescribed to control symptoms.
-
What to do if your dog is at risk
Actions
- Keeping your affected dog comfortable and giving them the best quality of life you can are the only actions you can take at home.
-
Genetic Information
This mutation was first described in the Leonberger.
This disease is inherited in an autosomal dominant manner, meaning that only one copy of the mutation is necessary to show signs of the disease. However, this mutation has incomplete penetrance, meaning that not all dogs that carry the mutation will show signs of the disease.
Gene names:
GJA9 ‐ chr
Inheritance type:
dominant
Citations:
-
Breeds affected
This health condition affects the following breeds
Learn about your dog’s unique genetic health
Dog owners
Breed identification, health and trait insights, personalized care recommendations, and the world’s first canine relative finder—all in one leading dog DNA test.
Learn about the report for dog ownersShop the test
Breeding programs
Embark’s test for breeding programs is one comprehensive DNA test designed with your needs in mind.
Learn about the report for breedersShop the test
